TY - JOUR
T1 - European Guideline on Chronic Nausea and Vomiting-A UEG and ESNM Consensus for Clinical Management
AU - Malagelada, Carolina
AU - Keller, Jutta
AU - Sifrim, Daniel
AU - Serra, Jordi
AU - Tack, Jan
AU - Mulak, Agata
AU - Stengel, Andreas
AU - Aguilar, Ariadna
AU - Drewes, Asbjorn Mohr
AU - Josefsson, Axel
AU - Bonaz, Bruno
AU - Dumitrascu, Dan
AU - Keszthelyi, Daniel
AU - Barba, Elizabeth
AU - Carbone, Florencia
AU - Zerbib, Frank
AU - Marchegiani, Giovanni
AU - Hauser, Goran
AU - Gourcerol, Guillaume
AU - Tornblom, Hans
AU - Hammer, Heinz
AU - Aziz, Imran
AU - Matic, Jelena Rakic
AU - Mendive, Juan
AU - Nikaki, Kornilia
AU - Wauters, Lucas
AU - Alcala-Gonzalez, Luis
AU - Waluga, Marek
AU - Jinga, Mariana
AU - Corsetti, Maura
AU - Rommel, Nathalie
AU - Shidrawi, Ray
AU - De Giorgio, Roberto
AU - Kadirkamanathan, Sritharan
AU - Surdea-Blaga, Teodora
PY - 2025/4
Y1 - 2025/4
N2 - IntroductionChronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non-gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well-structured approach. If the initial investigation for structural, toxic and metabolic disorders is negative, digestive motility and gut-brain interaction disorders should be assessed. United European Gastroenterology (UEG) and the European Society for Neurogastroenterology and Motility (ESNM) identified the need for an updated, evidence-based clinical guideline for the management of chronic nausea and vomiting.MethodsA multidisciplinary team of experts in the field, including European specialists and national societies, participated in the development of the guideline. Relevant questions were addressed through a literature review and statements were developed and voted on according to a Delphi process.ResultsNinety-eight statements were identified and voted following the Delphi process. Overall agreement was high, although the grade of scientific evidence was low in many areas. Disagreement was more evident for some pharmacological treatment options. A diagnostic algorithm was developed, focussing on the differentiating features between gastrointestinal motility and gut-brain interaction disorders with predominant nausea and vomiting.ConclusionThese guidelines provide an evidence-based framework for the evaluation and treatment of patients with chronic nausea and vomiting.
AB - IntroductionChronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non-gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well-structured approach. If the initial investigation for structural, toxic and metabolic disorders is negative, digestive motility and gut-brain interaction disorders should be assessed. United European Gastroenterology (UEG) and the European Society for Neurogastroenterology and Motility (ESNM) identified the need for an updated, evidence-based clinical guideline for the management of chronic nausea and vomiting.MethodsA multidisciplinary team of experts in the field, including European specialists and national societies, participated in the development of the guideline. Relevant questions were addressed through a literature review and statements were developed and voted on according to a Delphi process.ResultsNinety-eight statements were identified and voted following the Delphi process. Overall agreement was high, although the grade of scientific evidence was low in many areas. Disagreement was more evident for some pharmacological treatment options. A diagnostic algorithm was developed, focussing on the differentiating features between gastrointestinal motility and gut-brain interaction disorders with predominant nausea and vomiting.ConclusionThese guidelines provide an evidence-based framework for the evaluation and treatment of patients with chronic nausea and vomiting.
KW - Delphi
KW - guidelines
KW - nausea
KW - vomiting
KW - FUNCTIONAL GASTROINTESTINAL DISORDERS
KW - CANNABINOID HYPEREMESIS SYNDROME
KW - QUALITY-OF-LIFE
KW - CHRONIC INTESTINAL PSEUDOOBSTRUCTION
KW - HIGH-RESOLUTION MANOMETRY
KW - SMALL-BOWEL MOTILITY
KW - GRANISETRON TRANSDERMAL SYSTEM
KW - CHRONIC UNEXPLAINED NAUSEA
KW - PROXIMAL GASTRIC-VAGOTOMY
KW - AUTONOMIC NERVE FUNCTION
U2 - 10.1002/ueg2.12711
DO - 10.1002/ueg2.12711
M3 - Article
SN - 2050-6406
VL - 13
SP - 427
EP - 471
JO - United European Gastroenterology Journal
JF - United European Gastroenterology Journal
IS - 3
ER -